(2020). ASSESSMENT OF THE ANTI-ANGIOGENIC EFFECT OF IMATINIB ON LARYNGEAL CARCINOMA CELL LINE (HEP2)”. Ain Shams Dental Journal, 17(1), 179-184. doi: 10.21608/asdj.2020.164434
MLA
. "ASSESSMENT OF THE ANTI-ANGIOGENIC EFFECT OF IMATINIB ON LARYNGEAL CARCINOMA CELL LINE (HEP2)”". Ain Shams Dental Journal, 17, 1, 2020, 179-184. doi: 10.21608/asdj.2020.164434
HARVARD
(2020). 'ASSESSMENT OF THE ANTI-ANGIOGENIC EFFECT OF IMATINIB ON LARYNGEAL CARCINOMA CELL LINE (HEP2)”', Ain Shams Dental Journal, 17(1), pp. 179-184. doi: 10.21608/asdj.2020.164434
VANCOUVER
ASSESSMENT OF THE ANTI-ANGIOGENIC EFFECT OF IMATINIB ON LARYNGEAL CARCINOMA CELL LINE (HEP2)”. Ain Shams Dental Journal, 2020; 17(1): 179-184. doi: 10.21608/asdj.2020.164434
)
View on SCiNiTO